89 related articles for article (PubMed ID: 164475)
1. Requirement of bromodeoxyuridine for the maintenance of "transformed" characteristics in bromodeoxyuridine dependent cells.
Horn D; Davidson RL
J Cell Physiol; 1975 Apr; 85(2 Pt 1):251-60. PubMed ID: 164475
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of plasminogen activator from the transformed phenotype in a 5-bromodeoxyuridine dependent mutant of Syrian hamster melanoma cells.
Rosenthal SL; Zucker D; Davidson RL
J Cell Physiol; 1978 Jun; 95(3):275-85. PubMed ID: 649664
[TBL] [Abstract][Full Text] [Related]
3. Bromodeoxyuridine-induced reversion of transformed characteristics in BHK21 cells: changes at the plasma membrane level.
Lage-Davila A; Krust B; Hofmann-Clerc F; Torpier G; Montagnier L
J Cell Physiol; 1979 Jul; 100(1):95-107. PubMed ID: 468922
[TBL] [Abstract][Full Text] [Related]
4. Reversible "transformation" of bromodeoxyuridine-dependent cells by bromodeoxyuridine.
Davidson RL; Horn D
Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3338-42. PubMed ID: 4530304
[TBL] [Abstract][Full Text] [Related]
5. The dissociation of the surface architecture described by enhanced lectin agglutinability and the transformed phenotype expressed as anchorage independence.
Noonan KD; Bouck N; di Mayorica G
J Cell Physiol; 1977 May; 91(2):201-7. PubMed ID: 193864
[TBL] [Abstract][Full Text] [Related]
6. Investigations of the mechanism of decreased tumorigenicity of cells grown in BrdU.
Rothschild H; Black PH
J Cell Physiol; 1973 Apr; 81(2):217-24. PubMed ID: 4348555
[No Abstract] [Full Text] [Related]
7. Establishment and preliminary growth characteristics of a transformed mouse cerebral microvessel endothelial cell line.
Robinson RA; TenEyck CJ; Hart MN
Lab Invest; 1986 May; 54(5):579-88. PubMed ID: 2871227
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of HLA-DR antigens by the human melanoma cell line CaCL 73-36 upon induction of a less differentiated phenotype with bromodeoxyuridine.
Kawakubo Y; Liao SK
Anticancer Res; 1986; 6(5):1197-204. PubMed ID: 3800326
[TBL] [Abstract][Full Text] [Related]
9. Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody.
Morstyn G; Hsu SM; Kinsella T; Gratzner H; Russo A; Mitchell JB
J Clin Invest; 1983 Nov; 72(5):1844-50. PubMed ID: 6355188
[TBL] [Abstract][Full Text] [Related]
10. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
Nagashima T; Hoshino T
No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
[TBL] [Abstract][Full Text] [Related]
11. Requirement of long progression time for the expression of neoplastic phenotypes following direct perturbation to specific region(s) of DNA of Syrian hamster embryo cells.
Tsutsui T; Ts'o PO
Cancer Res; 1986 Jul; 46(7):3533-7. PubMed ID: 3708584
[TBL] [Abstract][Full Text] [Related]
12. Patching, microvilli, and the agglutination of normal and transformed cells.
Ukena TE; Karnovsky MJ
Prog Clin Biol Res; 1976; 9():261-73. PubMed ID: 1030804
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between growth characteristics, agglutinability by plant lectins and the malignant phenotype.
Berman LD
Int J Cancer; 1975 Jun; 15(6):973-9. PubMed ID: 1150351
[TBL] [Abstract][Full Text] [Related]
14. The cellular effect of 5-bromodeoxyuridine on the mammalian embryo.
Bannigan J; Langman J
J Embryol Exp Morphol; 1979 Apr; 50():123-35. PubMed ID: 458350
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric cell cycle analysis using the quenching of 33258 Hoechst fluorescence by bromodeoxyuridine incorporation.
Böhmer RM
Cell Tissue Kinet; 1979 Jan; 12(1):101-10. PubMed ID: 369699
[TBL] [Abstract][Full Text] [Related]
16. Requirements for and kinetics of growth arrest of neoplastic cells by confluent 10T1/2 fibroblasts induced by a specific inhibitor of cyclic adenosine 3':5'-phosphodiesterase.
Bertram JS; Faletto MB
Cancer Res; 1985 May; 45(5):1946-52. PubMed ID: 2985240
[TBL] [Abstract][Full Text] [Related]
17. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
18. Wheat germ agglutinin titres of normal and transformed Chinese hamster cells and human and guinea pig erythrocytes: variations related to cell preparation.
Cronin AP; Sanders FK
Cytobios; 1971 Dec; 4(15):177-81. PubMed ID: 4339592
[No Abstract] [Full Text] [Related]
19. [Flow cytometric measurements of in vivo incorporated bromodeoxy- uridine into the DNA of experimental and human tumors].
Kärcher H; McNally NJ; Wilson G; Kärcher KH; Pfragner R
Wien Klin Wochenschr; 1985 Nov; 97(22):850-5. PubMed ID: 4082602
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of bromodeoxyuridine incorporation into DNA of squamous carcinoma cells during mid and late logarithmic growth.
Shapira A; Wagner JG; Wollner IS; Maybaum J; Stetson PL; Ensminger WD; Carey TE
Pharm Res; 1988 Aug; 5(8):518-22. PubMed ID: 3244661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
